NVDA
NVIDIA
-- 139.930 RGTI
Rigetti Computing
-- 15.4400 TSLA
Tesla
-- 454.130 LAES
SEALSQ Corp
-- 8.760 KULR
KULR Technology
-- 4.8000 
$BioNTech (BNTX.US)$ The first colorectal cancer patient has...
$BioNTech (BNTX.US)$
The first colorectal cancer patient has been treated with BioNTech's (NASDAQ:BNTX) individualized mRNA cancer vaccine BNT122 (autogene cevumeran, RO7198457) in a Phase 2 clinical trial.
The first colorectal cancer patient has been treated with BioNTech's (NASDAQ:BNTX) individualized mRNA cancer vaccine BNT122 (autogene cevumeran, RO7198457) in a Phase 2 clinical trial.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Pochong : Not yet in the news leh. Where is this source from? FDA filing? Seeking Alpha? Benzinga?
Pochong : Ok saw. Sorry
mychoo : very sad...drop like nobody business everyday
102355763 : Needs Temasek to pump in more money
Kimchiano OP : Yea man. What Gg on sia